Eur Rev Med Pharmacol Sci 2020; 24 (6): 3404-3410
DOI: 10.26355/eurrev_202003_20711

Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha

F. Zheng, W. Tang, H. Li, Y.-X. Huang, Y.-L. Xie, Z.-G. Zhou

Department of Infectious Diseases, The First Hospital of Changsha, Changsha, Hunan, China. 1286779459@qq.com


OBJECTIVE: In December 2019, a new type of coronavirus-infected pneumonia broke out in Wuhan and spread rapidly to other parts of the country. The purpose of this study was to investigate the clinical features of coronavirus disease 2019 (COVID-19).

MATERIALS AND METHODS: A retrospective analysis was performed on the confirmed cases of COVID-19, who were admitted to the North Hospital of Changsha first Hospital (Changsha Public Health treatment Center) from January 17 to February 7, 2020.

RESULTS: The median age of COVID-19 patients was 45 years (range 33.5-57). The male patients accounted for 49.7%, 64.6% of the patients had a history of exposure in Wuhan, and 31.7% had family aggregation. The median days of onset were six, and the incidence of severe illness was 18.6%. Compared with the non-severe group, the severe group showed statistical significance in older age, hypertension, bilateral lung plaque shadow, decrease in lymphocyte count, increase in C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase, and creatine kinase.

CONCLUSIONS: Age, combined hypertension, oxygenation index, double lung patch, decreased lymphocyte count, and elevated levels of C-reactive protein, aspartate aminotransferase, lactate dehydrogenase, and creatine kinase can be used as predictors of the disease severity.

Free PDF Download

To cite this article

F. Zheng, W. Tang, H. Li, Y.-X. Huang, Y.-L. Xie, Z.-G. Zhou
Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 6
Pages: 3404-3410
DOI: 10.26355/eurrev_202003_20711